WJX-17667-25233
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 007 / PR
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-03
Dose 1 — Moderna
-
2021-01-07
Registered in v-safe
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-11
- 2021-01-17
- 2021-01-24
-
2021-01-31
Dose 2 — Moderna
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-09
- 2021-02-14
- 2021-02-21
- 2021-03-02
- 2021-03-08
- 2021-08-03
-
2021-10-23
Dose 3 — Moderna
- 2021-10-25
- 2021-10-26
- 2021-10-28
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-29
- 2021-12-06
-
2022-01-24
Survey response — 3 months, dose 3MedDRA: Cough, Dyspnoea, Myalgia, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Shortness of breath. Fever, muscle pain, cogh, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-24
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-27
- 2022-02-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Moderna | |
| 2 | 2021-01-31 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-24 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: Shortness of breath. Fever, muscle pain, cogh, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release